Effectiveness of a 10‐Day Melarsoprol Schedule for the Treatment of Late‐Stage Human African Trypanosomiasis: Confirmation from a Multinational Study (ImpamelII)
The Journal of Infectious Diseases2005Vol. 191(11), pp. 1922–1931
Citations Over TimeTop 10% of 2005 papers
Caecilia Schmid, Michaleen Richer, Constantin Miaka Mia Bilenge, Théophile Josenando, François Chappuis, Claude R. Manthelot, Auguste Nangouma, F. Doua, Pedro Ndong Asumu, Pere P. Simarro, C. Burri, Impamel II Study
Abstract
The 10-day treatment schedule was well implemented in the field and was effective. It reduces treatment duration, drug amount, and hospitalization costs per patient, and it increases treatment-center capacity. The shorter protocol has been recommended by the International Scientific Council for Trypanosomiasis Research and Control for the treatment of late-stage HAT caused by Trypanosoma brucei gambiense.
Related Papers
- → Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign(2012)84 cited
- → Enzymatic formation of prostaglandin D2, E2, and F2α in the parasitic protozoan Trypanosoma brucei(2002)3 cited
- → Semicarbazide-sensitive amine oxidase kills African trypanosomes in vitro(2010)
- → Novel forms of oral melarsoprol cure CNS stage Trypanosoma brucei brucei infection in a murine model of human African trypanosomiasis(2008)
- → Human African Trypanosomiasis: The Smoldering Scourge of Africa(2023)